Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting protein kinases involved in inflammatory diseases and cancer. Its structure supports high selectivity and binding affinity to specific enzyme active sites, making it valuable in developing targeted therapies. Also explored in the design of small-molecule drugs due to its metabolic stability and favorable pharmacokinetic profile. Additionally, employed in structure-activity relationship (SAR) studies to optimize antitumor and anti-inflammatory agents.